May 06, 2020
On April 30, the Centers for Medicare and Medicaid Services (CMS) released a second Interim Final Rule and additional waivers that provide increased regulatory relief and flexibility for healthcare providers during the public health emergency. Through this rulemaking, CMS delayed the implementation of the Qualified Clinical Data Registry (QCDR) measure testing and data collection approval criteria by 1 year.
In consideration of clinicians’ limited resources and to reduce burden on clinicians and healthcare organizations that are responding to the COVID-19 pandemic, CMS is delaying the timeline for the QCDR measure approval criteria previously finalized in the CY 2020 Medicare Physician Final Fee Schedule.
Additional information about QCDRs can be found on this CMS guide and additional information about the current flexibilities for the Quality Payment Program can be found on this COVID-19 resource guide.